Biosyngen is a cell therapy company focusing on unmet needs with technology targeting solid tumors and lymphoproliferative diseases. The company’s first-in-class products have entered into Phase I/II clinical trials for nasopharyngeal cancer (ODD and Fast-Track), lymphoproliferative disease and lung cancer. The company continues to enrich its pipeline with further IND submissions.
Biosyngen drives its international strategy from the global headquarter in Singapore, with its clinical center situated in Guangzhou, China. Leverages on the public-private biopharma ecosystem for the better cause.
Committed to giving cancer patients a better chance to survive, our pipeline is enriched, covering other major indications which are on track for regulatory registration.
Biosyngen seeks breakthrough in collaborations, particularly in translational R&D and clinical development. The company has positioned GMP cell therapy manufacturing facilities in two locations - in Singapore and Guangzhou covering global needs.
To quicken drug development from bench-to-bedside, a parallel effort in the form of the Translational Medicine Centre is set up. It is public-private-partnership connecting stakeholders in R&D, Clinical Development, Hospitals, Pharma, Enterprises and Venture Capital.
Follow us on LinkedIn. For more information, visit our website at www.biosyngen.com
Company Details
- Employees
- 23
- Founded
- -
- Address
- 5 Tai Seng Avenue, #08-51,singapore
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.biosyngen.com
- HQ
- Hougang, North East Community Development Council
Biosyngen Questions
Biosyngen's website is http://www.biosyngen.com
Biosyngen's LinkedIn profile is https://sg.linkedin.com/company/biosyngen
Biosyngen has
23 employees.
View email and phone details for 23
employees at Biosyngen.
Biosyngen's industry is
Biotechnology Research
Biosyngen's top competitors are
Hummingbird Bioscience,
Koncord Clinical Research Mcallen,
Lion Tcr,
Advanced Cell Therapy And Research Institute, Singapore (Actris),
Immunoscape,
Scg Cell Therapy,
Koncord Clinical Research Services,
Tikva Allocell Pte Ltd,
Cliantha Research Limited,
Tessa Therapeutics Ltd.
Biosyngen's categories are Biotechnology Research
Biosyngen's founding year is 2016
